Zura Bio Ltd.
ZURA
We are a clinical-stage biotechnology company developing novel and differentiated medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with significant unmet medical need. These diseases are often chronic, biologically complex and difficult to treat, and many patients do not achieve durable disease control with currently available thera…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$94M
▼ -31.0% YoY
Op. Margin
–
ROIC
-46.50%
▼ -5.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$65M
▼ -130.6% YoY
Op. Cash Flow (TTM)
-$65M
▼ -130.9% YoY
Net Debt
-$188M
Net Cash Position
Cash & Equiv.
$188M
Continue Research
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ZURA
Held by ETFs
ZURA is in 4 US ETFs. The largest of them, with ZURA's weight in each:
Zura Bio (ZURA) in two numbers
Questions about Zura Bio
Does Zura Bio (ZURA) pay a dividend?
No. Zura Bio (ZURA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 27 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in ZURA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ZURA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.